Envestnet Boosts Stake in Merck & Co.

Envestnet Portfolio Solutions Inc., a financial investment company, revealed its significant stake in Merck & Co., Inc. (NYSE:MRK) through its recent Form 13F filing with the Securities and Exchange Commission.

The firm's holdings in Merck & Co., Inc. were worth $13.57 million at the end of the second quarter. Envestnet Portfolio Solutions Inc. boosted its stake by 28.3% during this period, purchasing an additional 23,240 shares.

This is not an isolated instance; several other institutional investors and hedge funds have modified their holdings in Merck & Co., Inc. recently. BlackRock Inc. increased its stake by 0.5%, owning 226,999,837 shares worth $29.17 billion after purchasing 1.07 million additional shares.

Analysts are optimistic about the company's pipeline and future growth prospects. Bank of America maintained a Buy rating, citing confidence from Merck’s chief medical officer and multiple potential oncology and other pipeline readouts expected over the next 12 to 18 months.